Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1572-1579

  Fenkell, Louis ^a,b,c   Assenholt, Marianne ^a   Nielsen, Søren Kynde ^a   Haie Meder, Christine ^d   Pötter, Richard ^e   Lindegaard, Jacob ^a   Tanderup, Kari ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Stronach Regional Cancer Centre   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cervical cancer; Image guided adaptive brachytherapy; Midline block; MRI guided brachytherapy; Parametrial boost

Indexed keywords

BRACHYTHERAPY; CERVICAL CANCERS; IMAGE-GUIDED; MIDLINE BLOCK; PARAMETRIAL BOOST;

DISEASES; ONCOLOGY; RADIOTHERAPY; RESONANCE; TUMORS;

MAGNETIC RESONANCE IMAGING;

CISPLATIN;

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANS AT RISK; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; RADIATION SHIELD; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CISPLATIN; COLON, SIGMOID; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; ORGANS AT RISK; PELVIC FLOOR; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RECTUM; TUMOR BURDEN; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 79952701272     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.031     Document Type: Article

References (27)

1. Wolfson AH, Abdel-Wahab M, Markoe AM, et al. A quantitative assessment of standard vs. customized midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 1997;37:237-242. (Pubitemid 27090158)
2. Dimopoulos JC, Kirisits C, Petric P, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006;66:83-90. (Pubitemid 44175668)
3. Kirisits C, Lang S, Dimopoulos J, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006;65:624-630.
4. Macdonald DM, Lin LL, Biehl K, et al. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:618-624.
5. Duan J, Kim RY, Elassal S, et al. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: A novel approach for improving cervical tumor dose coverage. Int J Radiat Oncol Biol Phys 2008;71:765-771.
6. Assenholt MS, Petersen JB, Nielsen SK, et al. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008;47:1337-1343.
7. Cheng JC, Peng LC, Chen YH, et al. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 2003;57:1010-1018. (Pubitemid 37324119)
8. Huang EY, Lin H, Hsu HC, et al. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol 2000;79:406-410.
9. Huang EY, Wang CJ, Hsu HC, et al. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: Combined effect of external parametrial dose and cumulative rectal dose. Gynecol Oncol 2004;95:101-108.
10. Koom WS, Sohn DK, Kim JY, et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 2007;68:1446-1454. (Pubitemid 47176797)
11. Georg P, Kirisits C, Goldner G, et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 2009;91:173-180.
12. ICRU report 38. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: International Commission on Radiation Units & Measurements; 1985.
13. Datta NR. From 'points' to 'profiles' in intracavitary brachytherapy of cervical cancer. Curr Opin Obstet Gynecol 2005;17:35-41.
14. Potter R, Kirisits C, Fidarova EF, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325-1336.
15. Tanderup K, Nielsen SK, Nyvang GB, et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010;94:173-180.
16. Tanderup K, Georg D, Potter R, et al. Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol 2010;20:121-129.
17. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235-245.
18. Potter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67-77. (Pubitemid 43131038)
19. Lindegaard JC, Tanderup K, Nielsen SK, et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:756-764.
20. Wachter-Gerstner N, Wachter S, Reinstadler E, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: Comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 2003;68:269-276. (Pubitemid 38373427)
21. Van de Kamer JB, De Leeuw AA, Moerland MA, et al. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer. Radiother Oncol 2010;94:248-253.
22. Barillot I, Horiot JC, Maingon P, et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies. Int J Radiat Oncol Biol Phys 2000;48:189-200. (Pubitemid 30488230)
23. Datta NR, Basu R, Das KJ, et al. Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix. Clin Oncol (R Coll Radiol) 2004;16:129-137. (Pubitemid 38344434)
24. Toita T, Kodaira T, Shinoda A, et al. Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): Patterns of care study in Japan. Int J Radiat Oncol Biol Phys 2008;70:788-794.
25. Potter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148-155. (Pubitemid 46783926)
26. Dimopoulos JC, Potter R, Lang S, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009;93:311-315.
27. Dimopoulos JC, Lang S, Kirisits C, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009;75:56-63.